nifedipine has been researched along with Atrophy, Muscle in 4 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 5.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| "Treatment with nifedipine alone appeared to have no effect on muscle mass or the amount of myofibrillar proteins." | 5.31 | Effect of treatment with nifedipine, an L-type calcium channel blocker, on muscular atrophy induced by hindlimb immobilization. ( Fujimoto, K; Wagatsuma, A; Yamada, S, 2002) |
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 1.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| "Treatment with nifedipine alone appeared to have no effect on muscle mass or the amount of myofibrillar proteins." | 1.31 | Effect of treatment with nifedipine, an L-type calcium channel blocker, on muscular atrophy induced by hindlimb immobilization. ( Fujimoto, K; Wagatsuma, A; Yamada, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thornton, AM | 1 |
| Zhao, X | 1 |
| Weisleder, N | 1 |
| Brotto, LS | 1 |
| Bougoin, S | 1 |
| Nosek, TM | 1 |
| Reid, M | 1 |
| Hardin, B | 1 |
| Pan, Z | 1 |
| Ma, J | 1 |
| Parness, J | 1 |
| Brotto, M | 1 |
| Soares, JM | 1 |
| Duarte, JA | 1 |
| Carvalho, J | 1 |
| Appell, HJ | 1 |
| Dalla Libera, L | 1 |
| Ravara, B | 1 |
| Angelini, A | 1 |
| Rossini, K | 1 |
| Sandri, M | 1 |
| Thiene, G | 1 |
| Battista Ambrosio, G | 1 |
| Vescovo, G | 1 |
| Wagatsuma, A | 1 |
| Fujimoto, K | 1 |
| Yamada, S | 1 |
4 other studies available for nifedipine and Atrophy, Muscle
| Article | Year |
|---|---|
Store-operated Ca(2+) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle.
Topics: Aging; Anilides; Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Sig | 2011 |
The possible role of intracellular Ca2+ accumulation for the development of immobilization atrophy.
Topics: Animals; Calcium; Homeostasis; Male; Mice; Muscles; Muscular Atrophy; Nifedipine | 1993 |
Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Biphenyl Compounds; Calcium Channel Blockers; Drug Evaluation, P | 2001 |
Effect of treatment with nifedipine, an L-type calcium channel blocker, on muscular atrophy induced by hindlimb immobilization.
Topics: Actins; Animals; Calcium Channel Blockers; Hindlimb Suspension; Male; Mice; Muscle, Skeletal; Muscul | 2002 |